Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedCore content updated with a government-operational notice and a new version tag (v3.2.0); a specific GRDC resource entry was removed (Tenosynovial giant cell tumor, diffuse type) and the version history shows a backward-incompatible removal from v3.1.0 to v3.2.0.SummaryDifference4%

- Check31 days agoChange DetectedUpdate includes a new revision version (v3.1.0) and new contact details; previous revision (v3.0.2) is removed. No evidence of changes to core content beyond the metadata and contact info.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.SummaryDifference0.2%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding references to Beijing and Shanghai, while removing previous location terms and certain resources related to genetic diseases.SummaryDifference3%

- Check74 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.